Dynavax Technologies Company

Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Technology: Tumor-Specific Antigens
Industry: Tumor-Specific Antigens
Headquarters: Berkeley, California, United States
Founded Date: 1996-01-01
Employees Number: 501-1000
Funding Status: IPO
Investors Number: 21
Total Funding: 1151532377
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-05-11
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership